🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Circulating tumour cells (CTCs) are detectable in the blood in around 50% o...
Status
Completed
Location
Basingstoke & North Hampshire Hospital
Start Date
2014-05
Trial ID
NCT02075606
Treatments Being Tested
The aim of the study is to identify predictive factors for the response to ...
Status
Completed
Location
University Hospital of Vienna
Start Date
2012-06
Trial ID
NCT01840449
Treatments Being Tested
An open-label, Phase II clinical study to evaluate the efficacy and safety ...
Status
Completed
Location
UZ Leuven, Gasthuisberg
Start Date
2011-03
Trial ID
NCT01315795
Treatments Being Tested
The primary aim of this study is to assess which method of lanreotide Autog...
Status
Completed
Location
Aarhus University Hospital / Medisinsk afd. V
Start Date
2008-06
Trial ID
NCT00681187
Treatments Being Tested
To evaluate the long-term efficacy and safety of repeated injections of lan...
Status
Completed
Location
Hôpital Sud
Start Date
2000-09
Trial ID
NCT00210457
Treatments Being Tested
The purpose is to compare the efficacy and safety of lanreotide autogel® 60...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2014-10
Trial ID
NCT02493517
Treatments Being Tested
This is a long term study to evaluate common therapeutic algorithms and pos...
Status
Terminated
Location
St Vincent's Hospital
Start Date
2014-08
Trial ID
NCT02020499
Treatments Being Tested
The aim of this study is to compare the efficacy and safety of lanreotide A...
Status
Terminated
Location
Larry Kvols, MD
Start Date
2004-07
Trial ID
NCT00092287